| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.01 |